Tobacco-Based Vaccine for COVID? UK Company Ready For Human Trials

Tobacco-Based Vaccine for COVID? UK Company Ready For Human Trials

Published16 May 2020, 08:12 AM IST
Fit
1 min read

Cigarette maker British American Tobacco (BAT) has claimed it is ready to test its potential COVID-19 vaccine using proteins from tobacco leaves. The company claimed on Friday it is ready for human trials, as pre-clinical trials generated a positive immune response.

They are awaiting approval from US Food and Drug Administration (USFDA) to proceed to Phase 1 human trials.

The FDA has accepted the submission for BAT's pre-investigative new drug application, reports Reuters. They will also reach out to other governments around the world to develop the vaccine. If all approvals come in, the company could conduct clinical trials as early as June end.

UK-based BAT is known for their Lucky Strikes cigarettes. On its website, the company claims they could manufacture 1 and 3 million doses of the vaccine per week.

(The Quint is now available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!